Tag: pharma technology
-
Semarion raises $3.8 million to scale SemaCyte platform for drug discovery
Semarion has secured $3.8 million in a major Semarion funding round, signaling growing investor confidence in next-generation cell assay innovation and scalable drug discovery tools. The Cambridge-based biotechnology company plans to use the investment to accelerate adoption of its SemaCyte platform technology, expand manufacturing capacity, and strengthen its commercial footprint across global pharmaceutical markets. The…